Diamond Biofund Inc. (6901.TW)

TWD 21.65

(-4.2%)

EBITDA Summary of Diamond Biofund Inc.

  • Diamond Biofund Inc.'s latest annual EBITDA in 2023 was -2.59 Billion TWD , down -388.2% from previous year.
  • Diamond Biofund Inc.'s latest quarterly EBITDA in 2024 Q2 was -125.67 Million TWD , down -6.37% from previous quarter.
  • Diamond Biofund Inc. reported an annual EBITDA of 892.83 Million TWD in 2022, down -69.97% from previous year.
  • Diamond Biofund Inc. reported an annual EBITDA of 2.97 Billion TWD in 2021, down -51.48% from previous year.
  • Diamond Biofund Inc. reported a quarterly EBITDA of -800.34 Million TWD for 2024 Q1, down -118.5% from previous quarter.
  • Diamond Biofund Inc. reported a quarterly EBITDA of -24.13 Million TWD for 2023 Q1, up 97.7% from previous quarter.

Annual EBITDA Chart of Diamond Biofund Inc. (2023 - 2019)

Historical Annual EBITDA of Diamond Biofund Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -2.59 Billion TWD -388.2%
2022 892.83 Million TWD -69.97%
2021 2.97 Billion TWD -51.48%
2020 6.12 Billion TWD 11468.7%
2019 -53.89 Million TWD 0.0%

Peer EBITDA Comparison of Diamond Biofund Inc.

Name EBITDA EBITDA Difference